| Serial Number | 97230276 |
| Word Mark | MEDILINK |
| Filing Date | Thursday, January 20, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 14, 2024 |
| Registration Number | 7388604 |
| Registration Date | Tuesday, May 14, 2024 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 13, 2023 |
| Description of Mark | The mark consists of the stylized wording "MEDILINK". |
| Pseudo Mark | MED I LINK |
| Translation of Words in Mark | The wording "MEDILINK" has no meaning in a foreign language. |
| Goods and Services | Biochemical research and development; Biomedical research services; Biotechnology research; Chemical research; Chemical research and analysis; Chemistry consultation; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Professional consulting services and advice about agricultural chemistry; Research and development in the field of antibody-drug conjugates; Research and development in the field of antibody conjugates; Research and development in the field of drug conjugates; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research in the field of chemistry; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the nature of conducting clinical trials for others; Technology research in the field of pharmaceutical preparations and medical instruments; Testing of chemicals; Testing of cosmetics; Testing of pharmaceuticals |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 26, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, June 30, 2020 |
| First Use In Commerce Date | Tuesday, June 30, 2020 |
| Party Name | MediLink Therapeutics(Suzhou)Co.,Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Party Name | MediLink Therapeutics(Suzhou)Co.,Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Party Name | MediLink Therapeutics(Suzhou)Co.,Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Event Date | Event Description |
| Monday, January 24, 2022 | NEW APPLICATION ENTERED |
| Wednesday, January 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 28, 2022 | ASSIGNED TO EXAMINER |
| Monday, October 31, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, October 31, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, October 31, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 24, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 13, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 13, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 8, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 22, 2023 | USE AMENDMENT FILED |
| Tuesday, August 22, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Monday, August 28, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, August 28, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, September 20, 2023 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, September 20, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 31, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 19, 2024 | ASSIGNED TO LIE |
| Tuesday, March 19, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 11, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, May 14, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 14, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Friday, April 12, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |